K-EFFERVESCENT description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

K-EFFERVESCENT

Qualitest Pharmaceuticals
Tower Laboratories Ltd




FULL PRESCRIBING INFORMATION

CLINICAL PHARMACOLOGY:  Potassium ion is the principal intracellular cation of most body tissues.  Potassium ions participate in many essential physiological processes, such as the maintenance of intracellular tonicity, nerve impulse transmission, enzymatic reactions in intermediary metabolism, cardiac, skeletal and smooth muscle function, and the maintenance of normal renal function.

Potassium depletion may occur whenever the rate of potassium loss through renal excretion and/or loss from the gastrointestinal tract exceeds the rate of potassium intake.  Potassium depletion usually develops slowly as a result of lengthy therapy with oral diuretics, primary or secondary hyperaldosteronism, diabetic ketoacidosis, or inadequate replacement of potassium in patients on prolonged parenteral nutrition.  Depletion is additionally associated with severe diarrhea, accompanied by vomiting.  Potassium depletion due to these causes is usually accompanied by a concomitant loss of chloride and is manifested by hypokalemia and metabolic alkalosis.  Potassium depletion may result in fatigue, weakness, nausea, drowsiness, loss of appetite, edema, oliguria and chronic ileus with distention.  Potassium deficiency may be manifested by shallow breathing, lowered blood pressure, disturbances of cardiac rhythm (primarily ectopic beats), prominent U-waves in the electrocardiogram, or other ECG changes, such as lengthened Q-T interval, depressed S-T segment, and depressed or inverted T-wave.  In advanced cases of potassium deficiency, flaccid paralysis and/or impaired ability to concentrate urine may be evident.

Uses

INDICATIONS AN USAGE:









CONTRAINDICATIONS:
WARNINGS:
PRECAUTIONS:
Information for Patients
Laboratory Tests
Drug Interactions
Usage in Pregnancy
Nursing Mothers
Pediatric Use
ADVERSE REACTIONS:


OVERDOSAGE:




DOSAGE AND ADMINISTRATION:

Boxes of 30 tablets

 K-EFFERVESCENT

K-EFFERVESCENT

POTASSIUM BICARBONATE TABLET, EFFERVESCENT

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:0603-4170
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
POTASSIUM BICARBONATE 25 meq

Inactive Ingredients

Ingredient Name Strength
sorbitol
ANHYDROUS CITRIC ACID
SACCHARIN SODIUM ANHYDROUS
POLYETHYLENE GLYCOL 8000
SODIUM BENZOATE

Product Characteristics

Color Size Imprint Code Shape
orange 25 mm T ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0603-4170-16 30 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2006-01-06


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.